PROCEEDINGS OF THE British Pharmacological Society
1979; Wiley; Volume: 66; Issue: 1 Linguagem: Inglês
10.1111/j.1476-5381.1979.tb16098.x
ISSN1476-5381
Tópico(s)Pharmacology and Obesity Treatment
ResumoBritish Journal of PharmacologyVolume 66, Issue 1 p. 64P-157P Free Access PROCEEDINGS OF THE British Pharmacological Society First published: May 1979 https://doi.org/10.1111/j.1476-5381.1979.tb16098.xAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Reference LOWN, B., KLEIN, M.D., BARR, I., HAGEMEYER, F., KOSOWSKY, B.D. & GARRISON, H. (1972). Sensitivity to digitalis drugs in acute myocardial infarction. Am. J. Cardiol., 30, 388– 395. References HUGGINS, C., GRAND, L.C. & BRILLANTES, F.P. (1961). Mammary cancer induced by a single feeding of polynuclear hydrocarbons and its suppression. Nature Lond., 189, 204– 207. JORDAN, V.C. & JASPAN, T. (1976). Tamoxifen as an antitumour agent: oestrogen binding as a predictive test for tumour response. J. Endocr., 68, 453– 460. JORDAN, V.C. & NAYLOR, K.E. (1978). The antitumour activity of tamoxifen and monohydroxytamoxifen: a comparative study in the rat. Br. J. Pharmac., 64, 376– 377P. References BOREL, J.F. & WIESINGER, D. (1977). Effect of cyclosporin A on murine lymphoid cells. In: Regulatory Mechanisms in Lymphocyte Activation. (ed. by D.O. Lucas), 716– 718 ( Academic Press, New York). BOREL, J.F., FEURER, C., MAGNEE, C. & STAHELIN, H. (1977). Effects of the new anti-lymphocytic peptide cyclosporin A in animals. Immunology, 32, 1017– 1025. MISHELL, R.I. & DUTTON, R.W. (1966). Immunisation of normal mouse spleen cell suspensions in vitro. Science, 153, 1004– 1006. References HEPPNER, G.H. & CALABRESI, P. (1976). Selective suppression of humoral immunity by antineoplastic drugs. Ann. Rev. Pharmac. Toxicol, 16, 367– 379. KERKHAERT, J.A.M., van den BERG, G.J. & WILLERS, J.M.N. (1974). Influence of cyclophosphamide on the delayed hypersensitivity of the mouse. Ann. Immunol., 125C, 415– 426. LAGRANGE, P.H., MACKANESS, G.B. & MILLER, T.E. (1974). Potentiation of T-cell mediated immunity by selective suppression of antibody formation with cyclophosphamide. J. exp. Med., 139, 1529– 1539. TURK, J.L., PARKER, D. & POULTER, L.W. (1972). Functional aspects of the selective depletion of lymphoid cells of cyclophosphamide. Immunology, 23, 493– 501. TURK, J.L. & POULTER, L.W. (1972). Selective depletion of lymphoid tissue by cyclophosphamide. Clin. exp. Immunol., 10, 285– 296. References DOUGLAS, W.W. (1970). Histamine and antihistamines. In The Pharmacological Basis of Therapeutics, 4th edn. ed. L.S. Goodman & A. Gilman Macmillan, N.Y. P. 636. LICHTENSTEIN, L.M. & GILLESPIE, E. (1975). The effects of H1 and H2 antihistamines on allergic histamine release and its inhibition by histamine. J. Pharmac. exp. Ther., 192, 441– 450. References BOASSON, E.H. (1938). On the bacteriolysis by lysosyme. J. Immun., 34, 281– 293. BÖYUM, A. (1968). Isolation of mononuclear cells and granulocytes from human blood. Scand. J. clin. Lab. Invest., 21, Suppl. 97, 77– 89. FOREMAN, J.C, HALLETT, M.B. & MONGAR, J.L. (1977). Movement of strontium into mast cells and its relationship to the secretory response. J. Physiol. Lond., 271, 233– 251. GOLDSTEIN, I.M., HORN, J.K., KAPLAN, H.B. & WEISSMANN, G. (1974). Calcium-induced secretion from human polymorphonuclear leukocytes. Biochem. biophys. Res. Commun., 60, 807– 812. TALALAY, P., FISHMAN, W.H. & HUGGINS, C. (1946). Chromogenic substrates. II Phenolphthalein glucuronic acid as a substrate for the assay of glucuronidase activity. J. Biol. Chem., 116, 757– 772. WROBLEWSKI, F. & LADUE, J.S. (1955). Lactic dehydrogenase activity in blood. Proc. Soc. exp. Biol. Med., 90, 210– 217. WRIGHT, D.G., BRALOVE, D.A. & GALLIN, J.I. (1977). The differential mobilization of human neutrophil granules. Am. J. Path., 87, 273– 284. ZABUCCHI, G., SORANZO, M.R., ROSSI, F. & ROMEO, D. (1975). Exocytosis in human polymorphonuclear leukocytes induced by A23187 and calcium. FEBS Letters, 54, 44– 48. References HUTCHINSON, T.P. (1977). The method of m rankings where the total number of observations in each cell are not unity. Comput. & Biomed. Res., 10, 345– 361. ZAUGG, R.M., WALDER, J.A. & KLOTZ, I.M. (1977). SchifT base adducts of haemoglobin. J. biol. Chem., 252, 8542– 8548. References BALAN, G., CERNÅTESCU, D., TRANDAFIRESCU, M. & ABABEI, L. (1974). Influence of lithium on hexokinase and pyruvate kinase activity. Rev. Med-Chir. Soc Med. Nat. Iasi, 78, 901– 6. BIRCH, N.J. (1978). Metabolic effects of lithium. In Lithium in Medical Practice ed. F.N. Johnson & S. Johnson Pp. 89– 114, Lancaster, M.T.P. BIRCH, N.J., HULLIN, R.P., INIE, R.A. & LEAF, F.C. (1974). Effect of lithium on the activity of pyruvate kinase and other magnesium dependent enzymes. Br. J. Pharmac., 52, 139P. O'BRIEN, M.J., ALLIN, C.N., BIRCH, N.J. & HULLIN, R.P. (1977). Inhibition of rabbit muscle pyruvate kinase by lithium. Br. J. Pharmac., 61, 121P– 122P. PARKINSON, J. & EASTERBY, J.S. (1977). Purification and characterisation of bovine heart pyruvate kinase. Biochim. Biophys. Acta., 481, 471– 480. References SPECTOR, R.G. (1972). Influence of folic acid on excitable tissues. Nature New Biol., 240, 247– 249. JENKINS, D. & SPECTOR, R.G. (1973). The actions of folate and phenytoin on the rat heart in vivo and in vitro. Biochem. Pharmac., 22, 1813– 1816. JENKINS, D. & SPECTOR, R.G. (1976). Folate, catecholamines and bacterial respiration. Biochem. Pharmac., 25, 487. References GOTTESFELD, Z. & ELAZAR, Z. (1975). GAB A synthesis and uptake in penicillin focus. Brain Res. 84, 346– 50. HILL, R.G., SIMMONDS, M.A. & STRAUGHAN, D.W. (1973). A comparative study of some convulsant substances as γ-aminobutyric acid antagonists in the feline cerebral cortex. Br. J. Pharmac., 49, 37– 51. ROBERTS, E. & SIMONSEN, D.G. (1963). Some properties of l-glutamic decarboxylase in mouse brain. Biochem. Pharmac., 12, 113– 134. TABERNER, P.V. (1976). The anticonvulsant activity of the dissociative anaesthetic ketamine against seizures induced in mice by pentylene-tetrazol and mercap-topropionic acid. Eur. J. Pharmac., 39, 305– 312. WOOD, J.D. (1975). The role of γ-aminobutyric acid in the mechanism of seizures. Prog. in Neurobiol. 5, 77– 95. Reference STEVENS, J.T., STITZEL, E.R. & MCPHILLIPS, J.J. (1972). Effects of anticholinesterase insecticides on hepatic microsomal metabolism. J. Pharm. xp. Therap., 181, 576– 583. References BLACKWELL, B. & MARLEY, E. (1966). Interactions of yeast extracts and their constituents with monoamine oxidase inhibitors. Br. J. Pharmac. Chemother., 26, 142– 161. BURKARD, W.P., GEY, K.F. & PLETSCHER, A. (1962). Differentiation of monoamine oxidase and diamine oxidase. Biochem. Pharmac., 11, 177– 182. IMRIE, P.R., MARLEY, E. & THOMAS, D.V. (1978). Metabolism and distribution of exogenous histamine in cats. Br. J. Pharmac., 64, 109– 122. ROBINSON, D.S., LOVENBERG, W., KEISER, H. & SJOERDSMA, A. (1968). Effect of drugs on human blood platelet and plasma amine oxidase activity in vitro and in vivo. Biochem. Pharmac., 17, 109– 119. SCHAYER, R.W. (1956). The metabolism of histamine in various species. Br. J. Pharmac., 11, 472– 473. THOMAS, D.V. & MARLEY, E. (1978). Separation of radioactive histamine and some of its metabolites by one dimensional paper chromatography. J. Chromatog. 148, 477– 483. References HOLTZMAN, J.L., GRAM, T.E., GIGON, P.L. & GILLETTE, J.R. (1968). The distribution of the components of mixed-function oxidases between the rough and the smooth endoplasmic reticulum of liver cells. Biochem. J., 110, 407– 412. LA DU, B.N., GAUDETTE, L., TROUSOF, N. & BRODIE, B.B. (1955). Enzymatic dealkylation of aminopyrine (pyramidon) and other alkylamines. J. biol. Chem., 214, 741– 752. LEBER, H.W. & SCHÜTTERLE, G. (1972). Oxidative drug metabolism in liver microsomes from uremic rats. Kidney Int., 2, 152– 158. MCCANCE, R.A. & MORRISON, A.B. (1956). The effects of equal and limited rations of water, and of 1, 2 and 3 per cent solutions of sodium chloride on partially nephrec-tomized and normal rats. Quart. J. exp. Physiol., 41, 365– 386. OMURA, T. & SATO, R. (1964). The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its haemoprotein nature. J. biol. Chem., 239, 2370– 2378. REIDENBERG, M.M. (1975). Drug metabolism in uraemia. Clin. Nephrol., 4, 83– 85. SMITH, J.W., SEIDL, L.G. & CHUFF, L.E. (1966). Studies on the epidemiology of adverse drug reactions. V. Clinical factors influencing susceptibility. Ann. intern. Med., 65, 629– 640. References BLEEHEN, TIRZA, CLARK, AMANDA & HOBBIGER, F. (1978). Poster communication this meeting. P. 17. DUKE, HELEN N. & VANE, J.R. (1968). An adverse effect of polyvinylchloride tubing used in extracorporeal circulation. Lancet, 2, 21– 23. ONO, K., TATSUKAWA, R. & WAKIMOTO, T. (1975). Migration of plasticizer from hemodialysis blood tubing. JAMA, 234, 948– 949. ROSSEEL, M.T. & BOGAERT, M.G. (1976). Contamination of plasma samples by plasticizers: another source. J. Pharm. Pharmac., 28, 942. References BLABER, L.C. & BOWMAN, W.C. (1963). Studies on the repetitive discharges evoked in motor nerve and skeletal muscle after injection of anticholinesterase drugs. Br. J. Pharmac., 20, 326– 344. BLEEHEN, TIRZA, CLARK, AMANDA & HOBBIGER, F. (1978). Poster communication this meeting, P. 17. BULBRING, E. (1946). Observations on the isolated phrenic nerve diaphragm preparation of the rat. Br. J. Pharmac., 1, 38– 61. RANG, H.P. & RITTER, J.M. (1971). The effect of disulfide bond reduction on the properties of cholinergic receptors in chick muscle. Mol. Pharmac., 7, 620– 631. References DOCHERTY, J.R. & McGRATH, J.C. (1977). Potentiation of cardiac sympathetic nerve responses in vivo by pancuronium bromide. Br. J. Pharmac., 61, 472– 473P. DURANT, N.N. (1978). A comparison, in the anaesthetised cat and monkey, of pancuronium with a mono-quaternary analogue. Proc. Vth Eur. Congr. Anaesthesiology, Paris, Excerpt. Med. 452, 240– 241. HUGHES, R. & CHAPPLE, D.J. (1976). Effects of non-depolarising neuromuscular blocking agents on peripheral autonomic mechanisms in cats. Br. J. Anaesth. 48, 59– 67. IVANKOVITCH, A.D., MILETICH, D.J., ALBRECHT, R.F. & ZAHED, B. (1975). The effect of pancuronium on myocardial contraction and catecholamine metabolism. J. Pharm. Pharmac., 27, 837– 841. References ADAMS, P.R. (1977). Voltage-jump analysis of procaine action at frog end-plate. J. Physiol. Lond. 268, 291– 318. COLQUHOUN, D., DREYER, F. & SHERIDAN, R.E. (1978). The action of tubocurarine at the neuromuscular junction. J. Physiol. Lond. 284, 171– 172P. KATZ, B. & MILEDI, R. (1978). A re-examination of curare action at the motor end-plate. Proc. Roy. Soc. B. in press. RANG, H.P. & RITTER, J.M. (1969). A new kind of drug antagonism: evidence that agonists cause a molecular change in acetylcholine receptors. Mol. Pharmacol. 5, 394– 411. References ADAMS, P.R. (1977). Voltage-jump analysis of procaine action at frog end-plate. J. Physiol. Lond., 268, 291– 318. ASCHER, P., LARGE, W.A. & RANG, H.P. (1978). The action of ganglion-blocking drugs studied by voltage clamp. J. Physiol. Lond., 280, 17P. ASCHER, P., MARTY, A. & NEILD, TO. (1978). The mode of action of antagonists of the excitatory response to acetylcholine in Aphysia neurones. J. Physiol. Lond., 278, 207– 235. BLACKMAN, J.G. (1959). The pharmacology of depressor bases. PhD thesis, University of New Zealand. FELTZ, A., LARGE, W.A. & TRAUTMANN, A. (1977). Analysis of atropine action at the frog neuromuscular junction. J. Physiol. Lond., 269, 109– 130. NEHER, E. & STEINBACH, J.H. (1978). Local anaesthetics transiently block currents through single acetylcholine-receptor channels. J. Physiol. Lond., 277, 153– 176. References BEDDELL, C.R., GOODFORD, P.J., NORRINGTON, F.E., WILKINSON, S. & WOOTTON, R. (1976). Compounds designed to fit a site of known structure in human haemoglobin. Br. J. Pharmac., 57, 201– 210. BEDDELL, C.R., SHEPPEY, G.C., BLUNDELL, T.L., SUSAKI, K., DOCKERILL, S. & GOODFORD, P.J. (1977). Symmetrical features in polypeptide hormone-receptor interactions. Int. J. Peptide Protein Res., 9, 161– 165. GOODFORD, P.J. (1978). Molecular Symmetry in Drug Design. Proc. VI Int. Symp. Med. Chem. (in press). SOBELL, H.M., SAKORE, T.D., TAVALE, S.S., CANEPA, F.G., PAULING, P. & PETCHER, T.J. (1972). Sterochemistry of a Curare alkaloid: 0,0; N-Trimethyl-d-tubocurarine. Proc. Nat. Acad. Sci. U.S.A., 69, 2212– 2215. References GREEN, AR., YOUDIM, M.B.H. & GRAHAME-SMITH, D.G. (1976). Quipazine: its effects on rat brain 5-hydroxytryptamine metabolism, monoamine oxidase activity and behaviour. Neuropharmacology, 15, 173– 179. HONG, E. & PARDO, E.G. (1966). On the pharmacology of 2- (1-piperanzinyl) quinoline. J. Pharmac. exp. Ther., 153, 259– 265. RODRIGUEZ, R., ROJAS-RAMIREZ, J.A. & DRUCKER-COLIN, R.R. (1973). Serotonin-like actions of quipazine on the central nervous system. Eur. J. Pharmac., 24, 164– 171. References DOUGLAS, W.W., KANNO, T. & SAMPSON, S.R. (1967). Effects of acetylcholine and other medullary secretagogues and antagonists on the membrane potential of adrenal chromaffin cells: an analysis employing techniques of tissue culture. J. Physiol. Lond., 188, 107– 120. SAXENA, P.R., van HOUWELINGEN, P. & BONTA, I.L. (1971). The effects of mianserin hydrochloride on the vascular responses evoked by 5-hydroxytryptamine and related vasoactive substances. Eur. J. Pharmac., 13, 295. STONE, A.C., WENGER, H.C., LUDDEN, C.T., STAVORSKI, J.M. & ROSS, C.A. (1960). Antiserotonin-antihistaminic properties of cyproheptadine. J. Pharmac. exp. Ther., 131, 73– 84. References RICHARDSON, P.D.I. & WITHRINGTON, P.G. (1976). The inhibition by glucagon of the vasoconstrictor actions of noradrenaline, angiotensin and vasopressin on the hepatic arterial vascular bed of the dog. Br. J. Pharmac., 57, 93– 102. RICHARDSON, P.D.I. & WITHRINGTON, P.G. (1977). The role of β-adrenoceptors in the responses of the hepatic arterial vascular bed of the dog to phenylephrine, isoprenaline, noradrenaline and adrenaline. Br. J. Pharmac., 60, 239– 249. RICHARDSON, P.D.I. & WITHRINGTON, P.G. (1978a). Pressure-flow relationships and effects of noradrenaline and isoprenaline on the simultaneously-perfused hepatic arterial and portal venous vascular beds of the dog. J. Physiol. (Lond.), (in press). RICHARDSON, P.D.I. & WITHRINGTON, P.G. (1978b). The effects of intraportal infusion of glucagon on the responses of the simultaneously-perfused hepatic arterial and portal venous vascular beds of the dog to periarterial nerve stimulation. J. Physiol. (Lond.), (in press). References ARUNLAKSHANA, O. & SCHILD, H.O. (1959). Some quantitative uses of drug antagonists. Br. J. Pharmac. Chemother., 14, 48– 58. AUGSTEIN, J., FARMER, J.B., LEE, T.B., SHEARD, P. & TATTERSALL, M.J. (1973). Selective inhibitors of slow reacting substance of anaphylaxis. Nature New Biology, 245, 215– 217. BERRY, P.A. & COLLIER, H.O.J. (1964). Bronchoconstrictor action and antagonism of a slow reacting substance from anaphylaxis of guinea-pig isolated lung. Br. J. Pharmac. Chemother., 23, 201– 216. BROCKLEHURST, W.E. (1962). Slow reacting substance and related compounds. Progr. Allergy, 6, 539– 558. DRAZEN, J.M. & AUSTEN, K.F. (1974). Effects of intravenous administration of slow reacting substance of anaphylaxis, histamine, bradykinin and prostaglandin F2α on pulmonary mechanics in the guinea-pig. J. clin. Invest., 58, 1679– 1685. LULICH, K.M., MITCHELL, H.W. & SPARROW, M.P. (1976). The cat lung strip as an in vitro preparation of peripheral airways: a comparison of β-adrenoceptor agonists, autacoids and anaphylactic challenge of the lung strip and trachea. Br. J. Pharmac., 58, 71– 79. ORANGE, R.P. & AUSTEN, K.F. (1969). Slow reacting substance of anaphylaxis. Adv. Immunol., 10, 105– 144. ORANGE, R.P., VALENTINE, M.D. & AUSTEN, K.F. (1968). Antigen-induced release of slow reacting substance of anaphylaxis (SRS-Arat) in rats prepared with homologous antibody. J. exp. Med., 127, 767– 782. References ALLY, A.I. & NAKATSU, K. (1976). Adenosine inhibition of isolated rabbit ileum and antagonism by theophylline. J. Pharmac. exp. Therap., 19, 208– 215. BURNSTOCK, G., CAMPBELL, G., SATCHELL, D. & SMYTHE, A. (1970). Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut. Br. J. Pharmac., 40, 688– 688. HOOPER, M. SPEDDING, M., SWEETMAN, A.J. & WEETMAN, D.F. (1978). The effects of 2–2′-pyridylisatogen on responses to adenosine 5′-triphosphate in isolated smooth muscle preparations. In Physiological and Regulatory Functions of Adenosine and Adenine Nucleotides. ed. by H.P. Baer, and G. Drum-Mond Raven Press New York. In press. OKWUASABA, F.K., HAMILTON, J.T. & COOK, M.A. (1977). Relaxations of guinea pig fundic strip by adenosine, adenine nucleotides and electrical stimulation; antagonism by theophylline and desensitization to adenosine and its derivatives. Eur. J. Pharmac., 46, 181– 198. SAWYNOK, J. & JHAMANDAS, K.H. (1976). Inhibition of acetylcholine release from cholinergic nerves by adenosine, adenine nucleotides and morphine; antagonism by theophylline. J. Pharmac. exp. Therap., 197, 379– 390. References HORACKOVA, M. & VASSORT, G. (1974). Excitation-contraction in frog heart. Effect of Veratrine. Pfluegers. Arch., 352, 291– 302. LANGER, G.A. (1976). Events at the cardiac sarcolemma: localization and movement of contractile-dependent calcium. Fed. Proc, 35, 1274– 1278. LANGER, G.A. & FRANK, J.S. (1972). Lanthanum in heart cell culture. Effect on calcium exchange correlated with its localization. J. Cell. Biol., 54, 441– 455. MAYER, C.J., VAN BREEMAN, C. & CASTEELS, R. (1972). The action of lanthanum and D600 on the calcium exchange in the smooth muscle cells of the guinea-pig taenia coli. Pfluegers. Arch., 337, 333– 350. NAYLER, W.G. (1973). An effect of Ouabain on the superficially located stores of calcium in cardiac muscle cells. J. Mol. Cell. Cardiol., 5, 101– 110. Reference CUATRECASAS, P. (1972). Isolation of the insulin receptor of liver and fat-cell membranes. Proc. Nat. Acad. Sci. USA., 69, 318– 322. Reference PERT, C.B. & SNYDER, S.H. (1973). Properties of opiatereceptor binding in rat brain. Proc. Nat. Acad. Sci. U.S.A., 70, 2243– 2247. References BURT, D.R., CREESE, I. & SNYDER, S.H. (1976). Properties of 3H-haloperiol and 3H-dopamine binding associated with dopamine receptors in calf brain membranes. Mol. Pharmacol., 12, 800– 812. LEE, T., SEEMAN, P., TOURTELLOTTE, W.W., FARLEY, I.J. & HORNYKIEWICZ, O. (1978). Binding of 3H-neuroleptics and 3H-apo morphine in schizophrenic brains. Nature. Lond., 274, 897– 900. OWEN, F., CROSS, A.J., CROW, T.J., LONGDEN, A., POULTER, M. & RILEY, G.J. (1978). Increased dopamine receptor sensitivity in schizophrenia. Lancet, ii, 223– 225. SEEMAN, P., LEE, T., CHAU-WONG, M., TEDESCO, J. & WONG, K. (1976). Dopamine receptors in human and calf brains, using 3H-apomorphine and an antipsychotic drug. Proc. Natl. Acad. Sci., 73, 4354– 4358. References CREESE, I., BURT, D.R. & SNYDER, S.H. (1975). Dopamine receptor binding; Differentiation of agonist and antagonist state with [3H]-dopamine and [3H]-haloperidol. Life Sci. 17, 993– 1002. NAGY, J.I., LEE, T., SEEMAN, P. & FIBIGER, H.C. (1978). Direct evidence for presynaptic and postsynaptic dopamine receptors in brain. Nature Lond. 274, 278– 281. TITELER, M., WEINREICH, P. & SEEMAN, P. (1977). New detection of brain dopamine receptors with [3H]-dihydroergocriptine. Proc. Nat. Acad. Sci. USA. 74, 9, 3750– 3753. References ALEXANDER, R.W., COOPER, B. & HANDIN, R.I. (1978). Characterization of the human platelet α-adrenergic receptor. J. Clin. Invest. 61, 1136– 1144. GREENBERG, D.A. & SNYDER, S.H. (1977). Selective labelling of α-noradrenergic receptors in rat brain with [3H]-dihdryoergokryptine. Life. Sci. 20, 927– 932. GUELLAEN, G., YATES-AGGERBECK, M., VAUQUELIN, G., STROSBERG, D. & HANOUE, J. (1978). Characterization with [3H]-dihydroergocryptine of the α-adrenergic receptor of the hepatic plasma membrane. J. Biol. Chem., 253, 114– 1120. JAKOBS, K.H., SAUR, W. & SCHULTZ, G. (1976). Reduction of adenylate cyclase activity in lystates of human platelets by the α-adrenergic component of epinephrine. J. Cyclic Nucleotide Res., 2, 381– 392. MARQUIS, N.R., BECKER, J.A. & VIGDAHL, R.L. (1970). Platelet aggregation, an epinephrine-induced decrease in cyclic-AMP synthesis. Biochem. Res. Commun., 39, 783– 789. MILLS, D.C.B. & ROBERTS, G.C.K. (1967). Effects of adrenaline on human blood platelets. J. Physiol. (Lond.) 193, 443– 453. NEWMAN, K.D., WILLIAMS, L.T., BISHOPRIC, N.H. & LEFKOWITZ, RJ. (1978). Identification of α-adrenergic receptors in human platelets by [3H]-dihdroergocryptine binding. J. Clin. Invest. 61, 395– 402. O'BRIEN, J.R. (1963). Some effects of adrenaline and anti-adrenaline compounds on platelets in vitro and in vivo. Nature. Lond. 200, 763– 764. WILLIAMS, L.T., MULLIKIN, D. & LEFKOWITZ, R.J. (1976). Identification ofα-adrenergic receptors in uterine smooth muscle membranes by [3H]-dihydroergocryptine. J. Biol. Chem. 251, 6915– 6923. References LANGER, S.Z. (1977). Presynaptic receptors and their role in the regulation of transmitter release. Br. J. Pharmac., 60, 481– 497. SHARMA, V.K. & BANERJEE, S.P. (1978). Presynaptic muscarinic cholinergic receptors. Nature, 272, 276– 278. STARKE, K. (1977). Regulation of noradrenaline release by presynaptic receptor systems. Rev. Physiol. Biochem. Pharmac., 77, 1– 124. WAGNER, J. & BRODDE, O. E. (1978). On the presence and distribution of alpha-adrenoceptors in the heart of various mammalian species. Naunyn-Schmiedeberg's Arch. Pharmac., 302, 239– 254. References CHENG, Y.C. & PRUSOFF, W.H. (1973). Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 inhibition (I50) of an enzymatic reaction. Biochem. Pharmac., 22, 3099– 3108. LANDS, A.M., ARNOLD, A., McAULIFF, J.P., LUDUENA, F.P. & BROWN, T.G. (1967). Differentiation of receptor systems activated by sympatomimetic amines. Nature. Lond., 214, 597– 598. MAUGER, J.P., MOURA, A.M. & WORCEAL, M. (1978). Pharmacology of the adrenoceptors and cholinoceptors of the BC3H1 non fusing muscle cell line. Br. J. Pharmac., 64, 29– 36. SCHUBERT, D., HARRIS, A.J., DEVINE, C.E. & HEINEMANN, S. (1974). Characterization of a unique muscle cell line. J. Cell. Biol., 61, 398– 413. References BARNETT, D.B., RUGG, E.L. & NAHORSKI. S.R. (1978). Direct evidence of two types of β-adrenoceptor binding site in lung tissue. Nature. Lond. 273, 166– 168. LANGER, S.Z. (1977). Presynaptic receptors and their role in the regulation of transmitter release. Br. J. Pharmac., 60, 481– 497. NAHORSKI, S.R. (1978). Heterogeneity of cerebral β-adrenoceptor binding sites in different vertebrate species. Eur. J. Pharmac., 51, 199– 209. WOLFE, B.B., HARDEN, K.T. & MOLINOFF, P.B. (1977). In vitro study of β-adrenergic receptors. A. Rev. Pharmac. Toxicol. 17, 575– 604. References BOND, J.B., HAILEY, D.M. & LADER, M.H. (1977). Plasma concentrations of benzodiazepines. Br. J. clin. Pharmac., 4, 51– 56. BOURGOIN, S., HERY, F., TERNAUX, J.P. & HAMON, M. (1975). Effects of benzodiazepines on the binding of tryptophan in serum. Consequences on 5-hydroxyindoles concentration in the rat brain. Psychopharmacologia Communications, 1, 209– 216. References CHANG, R.S.L., TRAN, V.T. & SNYDER, S.H. (1978). Histamine H, receptors in brain labeled with 3H-mepyramine. Eur. J. Pharmac., 48, 463– 464. HILL. S.J., EMSON, P.C. & YOUNG, J.M. (1978). The binding of [3H]-mepyramine to histamine H1 receptors in guinea-pig brain. J. Neurochem., in press. HILL, S.J. & YOUNG, J.M. (1978). Evidence for the presence of histamine H1 receptors in guinea-pig brain. Br. J. Pharmac., 63, 394P– 395P. HILL, S.J., YOUNG, J.M. & MARRIAN, D.H. (1977). Specific binding of 3H-mepyramine to histamine H1 receptors in intestinal smooth muscle. Nature. Lond., 260, 163– 165. WILKINSON. G.N. (1961). Statistical estimations in enzyme kinetics. Biochem.J., 80, 324– 332. References BALL, S.E., BOULLIN, D.J. & GLENTON, P.A.M. (1977). Interaction between noradrenaline and 5-hydroxytryptamine involving platelet aggregation. J. Phvsiol. Lond., 272, 98– 99P. BAUMGARTNER, H.R. & BORN, G.V.R. (1968). Effects of 5-hydroxytryptamine on platelet aggregation. Nature Lond., 218, 137– 141. BORN, G.V.R. & MICHAL, F. (1975). The 5-hydroxytryptamine receptors of platelets. In: Biochemistry and Pharmacology of platelets, ed.. K. Elliot & J. Knight, pp. 287– 307. Amsterdam: Elsevier. HOLMSEN, H. (1975). Biochemistry of the platelet release reaction. In: Biochemistry and Pharmacology of platelets, ed.. K. Elliot & J. Knight, pp. 175– 205. Amsterdam: Elsevier. OPPENHEIM, B. YOUDIM, M.B.H., GOLDSTEIN, S. & HEFETZ, A. (1978). Human platelets as a neuronal model for the study of the pharmacological activity of tryptolines and neuroleptics. Israel J. Med. Sci. (in press). YOUDIM, M.B.H., OPPENHEIM, B. & GOLDSTEIN, S. (1978). The effect of tryptolines on platelet aggregation and monoamine metabolism. Abstract 7th Inter. Cong. Parmacol, Paris. P720. Pergamon Press, Oxford, (in press). References BLACKWELL, G.J., FLOWER, R.J., RUSSELL-SMITH, N., SALMON, J.A., THOROGOOD, P.B. & VANE, J.R. (1978). Prostacyclin is produced whole blood. Br. J. Pharmac., in press. BORN, G.V.R. (1962). Quantitative investigations into the aggregation of blood platelets. J. Physiol. Lond., 162, 67P. CARDINAL, D.C. & FLOWER, R.J. (1979). The electronic platelet aggregometer. Br. J. Pharmac., 66, 138P. GRYGLEWSKI, R.J., KORBUT, R., OCETKIEWICZ, A. & STACHURA, T. (1978). In vivo method for quantitation of anti-platelet potency of drugs. Naunyn-Schmiedeberg's Arch. Pharmac., 302, 25– 30. HAMBERG, M., SVENSSON, J. & SAMUELSSON, B. (1975). Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Nat. Acad. Sci. U.S.A., 72, 2994– 2998. M
Referência(s)